Huntington's disease (HD) is a rare, progressive neurological disorder characterized by the degeneration of nerve cells in the brain. It is an inherited condition caused by a faulty gene on chromosome 4, leading to the production of a mutated form of the huntingtin protein. Symptoms usually manifest in mid-adulthood, with a wide range of cognitive, motor, and psychiatric impairments. Early signs may include involuntary movements, difficulty concentrating, and mood swings. As the disease advances, individuals may experience a decline in motor skills, leading to uncontrolled movements and difficulty with coordination. Cognitive functions, such as memory and reasoning, also deteriorate, impacting daily life. HD poses significant challenges for affected individuals and their families, as the progressive nature of the disease results in increased dependency and diminished quality of life. While there is no cure for Huntington's disease, supportive care and medications can help manage symptoms and improve the patient's well-being. Genetic testing allows individuals at risk to determine whether they carry the gene mutation, aiding in family planning decisions. Research continues in the quest for effective treatments and potential breakthroughs to modify the course of the disease. Huntington's disease has far-reaching implications for affected families, underscoring the importance of genetic counseling, psychological support, and multidisciplinary care. The global medical community remains dedicated to unraveling the complexities of HD to enhance our understanding and develop targeted interventions for this challenging condition.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia